The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Fexofast 180 mg Film-coated Tablets



Cipla Europe NVPA1963/014/002

Main Information

Trade NameFexofast 180 mg Film-coated Tablets
Active SubstancesFexofenadine hydrochloride
Dosage FormFilm-coated tablet
Licence HolderCipla Europe NV
Licence NumberPA1963/014/002

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX26 fexofenadine

Status

License statusAuthorised
Licence Issued22/07/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back